Re: Bioasis Announces Publication of CNS Delivery of siRNA via xB³ ™ Platform Technology
|
4
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 05:05PM
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 07:34AM
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2021 05:37PM
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2021 05:30PM
|
Re: great news: timelines for data readouts in new corporate presentation just released late yesterday
|
3
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2021 11:07AM
|
Re: Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
12
|
Resverlogix Corp.
|
Mar 17, 2021 08:10AM
|
Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell
|
8
|
Resverlogix Corp.
|
Mar 17, 2021 08:05AM
|
The cardiac pre-print now published....in Cell!
|
17
|
Resverlogix Corp.
|
Mar 16, 2021 10:25AM
|
Re: Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
|
8
|
Zenith Epigenetics
|
Mar 15, 2021 09:53PM
|
Re: Are we now a SARS Vaccine contender?
|
7
|
Resverlogix Corp.
|
Mar 15, 2021 01:35PM
|
Apabetalone Treatment Prevents COVID-19 Infection of Human Lung Cells
|
7
|
Resverlogix Corp.
|
Mar 15, 2021 01:31PM
|
Re: Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral
|
3
|
Resverlogix Corp.
|
Mar 15, 2021 01:30PM
|
Re: Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
|
3
|
Zenith Epigenetics
|
Mar 15, 2021 01:22PM
|
Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
|
3
|
Zenith Epigenetics
|
Mar 15, 2021 01:16PM
|
Re: Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA
|
4
|
Zenith Epigenetics
|
Mar 15, 2021 01:12PM
|
Re: ABL- COVID-19 Therapeutic
|
5
|
Resverlogix Corp.
|
Mar 07, 2021 10:22AM
|
Re: from J4P on SH , "I will go out on a limb with a prediction..." Good, Better, Best and Share price
|
4
|
Resverlogix Corp.
|
Mar 07, 2021 10:08AM
|
Re: By the Way.....
|
4
|
BIOASIS TECHNOLOGIES INC
|
Mar 04, 2021 11:47AM
|
Morphic Holding
|
|
BIOASIS TECHNOLOGIES INC
|
Mar 04, 2021 11:37AM
|
Re: New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19
|
4
|
Resverlogix Corp.
|
Mar 03, 2021 02:29PM
|